European Medicines Agency authorizes new technique for injecting Monkeypox vaccine to cover more people

European Medicines Agency authorizes new technique for injecting Monkeypox vaccine to cover more people

The European Medicines Agency argues that the vaccine can also be administered as an intradermal injection at a lower dose, thus allowing more people to be protected.

EMA authorizes new technique for injecting the vaccine against Monkeypox to cover more people

Currently, the vaccine was only authorized for subcutaneous injections (under the skin) and will now also be able to be used intradermally (injection just below the upper layer of the skin), provided it is in a lower dose.

EMA authorizes new method to administer vaccine against Monkeypox

The European Medicines Agency (EMA) approved, this Friday, the administration of the Imvanex vaccine intradermally (on the skin). So far, the vaccine was only authorized for subcutaneous injection (under the skin). As the new method, it will be possible to immunize more people against the so-called monkey pox.

Monkeypox. New vaccine injection technique authorized to cover more people

Oparecer da EMA surge depois de a ‘task force’ de emergência da agência ter analisado dados sobre aquela vacina e concluído que a mesma, atualmente só autorizada para injeções subcutâneas (sob a pele), também poder ser utilizada por via intradérmica (injeção logo abaixo da camada superior da pele), desde que numa dose menor, apontando que, desta forma, e face ao “fornecimento atualmente limitado da vacina”, mais pessoas podem ser vacinadas.A ‘ta…